Ashlyn Reiser, MD
Ophthalmology · Boynton Beach, FLNPI 1063031433
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Alcon at 28.8% of the total. 2025 is the largest year on record at $1,938, more than ten times the $193 reported in 2021.
Across 85 payments — averaging $60.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- NEW World Medical,inc.$909
- Bausch & Lomb Americas Inc.$778
- AbbVie$677
- Dompe US, Inc.$204
- Mallinckrodt Hospital Products Inc.$201
- plus $896 from 9 others
What the payments were for
- Travel & lodging$501%
- Food & beverage$5,01397%
- Education$882%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 15 | $1,486 |
| NEW World Medical,inc. | 12 | $909 |
| Bausch & Lomb Americas Inc. | 16 | $778 |
| AbbVie(2 entities) | 13 | $677 |
| Dompe US, Inc. | 3 | $204 |
| Mallinckrodt Hospital Products Inc. | 5 | $201 |
| Amgen(2 entities) | 3 | $165 |
| ANI Pharmaceuticals, Inc. | 7 | $165 |
| Genentech USA, Inc. | 1 | $137 |
| Apellis Pharmaceuticals, Inc. | 1 | $123 |
| Rxsight Inc | 1 | $112 |
| Glaukos Corporation | 3 | $83 |
| Tarsus Pharmaceuticals, Inc. | 3 | $76 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $19 |
| Oyster Point Pharma, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kahook Dual Blade$820
- Clearpath$820
- Ahmed Glaucoma Valve$820
- Streamline$820
- Via360$671
- AcrySof IQ PanOptix UV IOL$410
- enVista MX60 IOL$392
- Clareon$278
- DURYSTA$249
- STELLARIS$176
- AMVISC PLUS$176
- Oxervate$150
- Unity$138
- VABYSMO$137
- TEPEZZA$125
- Syfovre$123
- OZURDEX$123
- VUITY$123
- Hydrus Microstent$122
- ARGOS$122
How this compares
$5,151 in reported general payments places this provider in the 75th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 17 | $697 |
| Latanoprost | 18 | $108 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Boynton Beach
- Barry SchechterBoynton Beach$264K
- Cathleen McCabeBradenton$2M
- Daniel KiernanSarasota$1.7M
- David EichenbaumSt Petersburg$1.7M
- Mark MilnerPalm Beach Gardens$1.2M
- Neel DesaiLargo$1M
- Jorge FortunPalm Beach Gardens$798K
- Courtney BoveeTampa$796K
- Harold BrooksTallahassee$683K
- Robert WeinstockLargo$605K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.